This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Chemical Corporation. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Takeki Miyazaki: Innovator in Chemical Synthesis
Introduction
Takeki Miyazaki is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of chemical synthesis, particularly in the development of compounds that serve as intermediates in pharmaceuticals and agricultural chemicals. His work is recognized for its potential applications in various industries.
Latest Patents
Miyazaki holds a patent for "2-cyanopiperazine and method of producing the same." This compound, represented by the formula (1), can be produced by reacting a 2-halogenoacrylonitrile with ethylenediamine or by reacting a 2,3-dihalogenopropionitrile with ethylenediamine. The 2-cyanopiperazine is particularly useful as an intermediate for medicaments and agricultural chemicals. Notably, it can be utilized in the production of optically active N-tert-butyl-2-piperazine carboxamide, which is an important intermediate in the preparation of the HIV protease inhibitor indinavir.
Career Highlights
Miyazaki is associated with Mitsubishi Chemical Corporation, where he has been able to leverage his expertise in chemical synthesis. His innovative approach has led to advancements in the production of valuable chemical compounds. His work has not only contributed to the company's portfolio but has also had a broader impact on the pharmaceutical and agricultural sectors.
Collaborations
Miyazaki has collaborated with notable colleagues, including Yuki Takuma and Ken Okamoto. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the field of chemical research.
Conclusion
Takeki Miyazaki's contributions to chemical synthesis exemplify the importance of innovation in developing compounds that have significant applications in medicine and agriculture. His work continues to influence the industry and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile